Request Sample
Request Methodology
Description
Market Dynamics: Global Thrombectomy Devices Market
Technological advancements are the major driving factor of the market. In addition, rise in demand for minimally invasive surgeries, growth in ageing population is expected to boost the market share. Moreover, increase in prevalence of heart diseases coupled with the lifestyle changes expected to push the market growth. However, lack of the skilled professionals, limited awareness will hamper the market share over the forecast period.
Market Scope: Global Thrombectomy Devices Market
Global Thrombectomy Devices market is segmented based on product type, application, end user and region
Based on product type, market is segmented into
- Aspiration Thrombectomy Devices
- Rheolytic Thrombectomy Devices
- Mechanical Thrombectomy Devices
- Ultrasonic Thrombectomy Devices
Based on application, market is segmented into
- Peripheralvascular
- Neurovascular
- Cardiovascular
- Others
Based on end user, market is segmented into
- Hospitals
- Ambulatory Surgical Centers (ASC’s)
- Others
Based on Region, market is segmented into
- North America
- Latin America
- Asia Pacific
- Europe
- Middle East and Africa (MEA)
Regional Analysis: Global Thrombectomy Devices Market
North America thrombectomy devices market is anticipated have significant growth rate due to increase in prevalence of cardiovascular diseases and presence of the key market players. Asia Pacific thrombectomy devices market is expected to have the lucrative growth opportunity owing to developing healthcare infrastructure, prevalence of the cardiovascular diseases and growing awareness & demand for the minimally invasive surgeries.
Competition Assessment:
- Johnson & Johnson (U.S.)
- Medtronic plc (U.S)
- Penumbra, Inc. (U.S.)
- Boston Scientific Corporation (U.S.)
- Edwards Lifesciences Corporation (U.S.)
- Terumo Corporation (Japan)
- Argon Medical Devices, Inc. (U.S.)
- Spectranetics Corporation (U.S.)
- Teleflex Incorporated (U.S.)
Notable Market Developments:
- Penumbra, Inc. has launched Separator 3D, an advanced thrombectomy device to treat cerebral occlusions that causes ischemic stroke
Key Features of the Report:
- The report provides granular level information about the market size, regional market share, historic market (2015-2019) and forecast (2020-2026)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Location
GEOGRAPHY
